Mary J. Tanga
6Patents
2h-index
11Co-inventors
40Inventor score
Filing activity: Oct 10, 2008 → Nov 2, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9650352B2 | Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain | Chemistry; Metallurgy | 19 | Active |
| US9867830B2 | Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain | Chemistry; Metallurgy | 9 | Active |
| US8410138B2 | Compounds for activating TGF-beta signaling | Chemistry; Metallurgy | 2 | Active |
| US8097645B2 | Compounds for activating TGF-β signaling | Chemistry; Metallurgy | 1 | Active |
| US8664009B2 | Arsenical fluorescent agents and assays | Physics | 0 | Active |
| US9796674B2 | Benzyl urea derivatives for activating TGF-beta signaling | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.